Wird geladen...
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis
AIM: Our goal was to improve treatment outcomes for visceral leishmaniasis by designing nanocarriers that improve drug biodistribution and half-life. Thus, long-acting mannose-anchored thiolated chitosan amphotericin B nanocarrier complexes (MTC AmB) were developed and characterized. MATERIALS &...
Gespeichert in:
| Veröffentlicht in: | Nanomedicine (Lond) |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Future Medicine Ltd
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5144491/ https://ncbi.nlm.nih.gov/pubmed/27879160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm-2016-0325 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|